Source:http://linkedlifedata.com/resource/pubmed/id/11576761
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
2001-9-28
|
pubmed:abstractText |
Using cDNA microarrays we have investigated gene expression patterns in brain regions of patients with schizophrenia. A cDNA neuroarray, comprised of genes related to brain function, was used to screen pools of samples from the cerebellum and prefrontal cortex from a matched set of subjects, and middle temporal gyrus, from a separate subject cohort. Samples of cerebellum and prefrontal cortex from neuroleptic naive patients were also included. Genes that passed a 3% reproducibility criterion for differential expression in independent experiments included 21 genes for drug-treated patients and 5 genes for drug-naive patients. Of these 26 genes, 10 genes were increased and 16 were decreased. Many of the differentially expressed genes were related to synaptic signaling and proteolytic functions. A smaller number of these genes were also differentially expressed in the middle temporal gyrus. The five genes that were differentially expressed in two brain regions from separate cohorts are: tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide; sialyltransferase; proteasome subunit, alpha type 1; ubiquitin carboxyl-terminal esterase L1; and solute carrier family 10, member 1. Identification of patterns of changes in gene expression may lead to a better understanding of the pathophysiology of schizophrenia disorders.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0361-9230
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
55
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
641-50
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:11576761-Adult,
pubmed-meshheading:11576761-Aged,
pubmed-meshheading:11576761-Brain,
pubmed-meshheading:11576761-Brain Chemistry,
pubmed-meshheading:11576761-Cerebellum,
pubmed-meshheading:11576761-Female,
pubmed-meshheading:11576761-Gene Expression Regulation,
pubmed-meshheading:11576761-Genetic Testing,
pubmed-meshheading:11576761-Humans,
pubmed-meshheading:11576761-Male,
pubmed-meshheading:11576761-Middle Aged,
pubmed-meshheading:11576761-Oligonucleotide Array Sequence Analysis,
pubmed-meshheading:11576761-Prefrontal Cortex,
pubmed-meshheading:11576761-RNA, Messenger,
pubmed-meshheading:11576761-Reproducibility of Results,
pubmed-meshheading:11576761-Schizophrenia,
pubmed-meshheading:11576761-Temporal Lobe
|
pubmed:year |
2001
|
pubmed:articleTitle |
Application of cDNA microarrays to examine gene expression differences in schizophrenia.
|
pubmed:affiliation |
Section on Plasticity and Development, Cellular Neurobiology Research Branch, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD, USA. mvawter@uci.edu
|
pubmed:publicationType |
Journal Article
|